SINOVAC BIOTECH LTD (SVA)
AGP8696W1045 - Common Stock
Sinovac Amends Shareholder Rights Plan
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
Sinovac Announces Change of Legal Representative of Sinovac Beijing
SINOVAC Reports Unaudited First Half of 2023 Financial Results
WHO recommends updating COVID shots to add XBB.1 variants
After a meeting of an advisory panel, the WHO announced its recommendations Thursday backing COVID shots updated for currently dominant XBB.1 strains. Read more here.
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
Sinovac Amends Shareholder Rights Plan
SINOVAC Reports Unaudited First Half of 2022 Financial Results
SINOVAC Varicella Vaccine Prequalified by WHO
SINOVAC to Showcase Products at CPHI Frankfurt
SVA DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sinovac Biotech Ltd. (SVA) Investors of Class Action Deadline Against 1Globe Capital LLC and to Actively Participate
SVA FINAL DEADLINE MONDAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...
Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Deadline in Lawsuit on October 17, 2022
San Diego, CA -- (SBWIRE) -- 10/10/2022 -- The Shareholders Foundation announced that a deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Sinovac Biotech Ltd. (formerly NASDAQ:SVA).
SVA FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...
ROSEN, A LEADING LAW FIRM, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11,...
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Lawsuit Alleges Securities Laws Violations by 1Globe Capital LLC
San Diego, CA -- (SBWIRE) -- 09/02/2022 -- An investor, who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ:SVA), filed a lawsuit over alleged Securities Laws violations by 1Globe Capital LLC.
SINOVAC BIOTECH LTD. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts
/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively Participate
Booster Shots Protect Against Severe Covid for at Least Six Months, Study Finds
A Covid-19 vaccine booster shot protects people from becoming severely ill or dying and its efficacy lasts for six months, according a study published in the Journal of the American Medical Association, underscoring the importance of additional jabs as the world moves to coexist with the virus.